You have full text access to this OnlineOpen article

Retraction: Fatty acid synthase is a novel therapeutic target in multiple myeloma

  1. Yutaka Okawa1,2,
  2. Teru Hideshima1,
  3. Hiroshi Ikeda1,
  4. Noopur Raje1,
  5. Sonia Vallet1,
  6. Tanyel Kiziltepe1,
  7. Hiroshi Yasui1,
  8. Sotaro Enatsu1,
  9. Samantha Pozzi1,
  10. Iris Breitkreutz1,
  11. Diana Cirstea1,
  12. Loredana Santo1,
  13. Paul Richardson1,
  14. Kenneth C. Anderson1

Article first published online: 11 APR 2008

DOI: 10.1111/j.1365-2141.2008.07114.x

Issue

British Journal of Haematology

British Journal of Haematology

Volume 141, Issue 5, pages 659–671, June 2008

Additional Information

How to Cite

Okawa, Y., Hideshima, T., Ikeda, H., Raje, N., Vallet, S., Kiziltepe, T., Yasui, H., Enatsu, S., Pozzi, S., Breitkreutz, I., Cirstea, D., Santo, L., Richardson, P. and Anderson, K. C. (2008), Retraction: Fatty acid synthase is a novel therapeutic target in multiple myeloma. British Journal of Haematology, 141: 659–671. doi: 10.1111/j.1365-2141.2008.07114.x

Author Information

  1. 1

    LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

  2. 2

    Division of Oncology and Haematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan

*Kenneth C. Anderson, MD, Dana-Farber Cancer Institute, Mayer 557, 44 Binney Street, Boston, MA 02115, USA. E-mail: kenneth_anderson@dfci.harvard.edu and Yutaka Okawa, MD, PhD, Dana-Farber Cancer Institute, Mayer 549, 44 Binney Street, Boston, MA 02115, USA. E-mail: yutaka_okawa@dfci.harvard.edu

  1. Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.

Publication History

  1. Issue published online: 15 APR 2008
  2. Article first published online: 11 APR 2008
  3. Received 30 October 2007; accepted for publication 7 January 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (876K)

References

  • Abraham, M.C. & Shaham, S. (2004) Death without caspases, caspases without death. Trends in Cell Biology, 14, 184–193.
  • Ahn, E.Y., Lim, S.T., Cook, W.J. & McDonald, J.M. (2004) Calmodulin binding to the Fas death domain. Regulation by Fas activation. Journal of Biological Chemistry, 279, 5661–5666.
  • Asturias, F.J., Chadick, J.Z., Cheung, I.K., Stark, H., Witkowski, A., Joshi, A.K. & Smith, S. (2005) Structure and molecular organization of mammalian fatty acid synthase. Nature Structural & Molecular Biology, 12, 225–232.
  • Bandyopadhyay, S., Zhan, R., Wang, Y., Pai, S.K., Hirota, S., Hosobe, S., Takano, Y., Saito, K., Furuta, E., Iiizumi, M., Mohinta, S., Watabe, M., Chalfant, C. & Watabe, K. (2006) Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells. Cancer Research, 66, 5934–5940.
  • Baron, A., Migita, T., Tang, D. & Loda, M. (2004) Fatty acid synthase: a metabolic oncogene in prostate cancer? Journal of Cellular Biochemistry, 91, 47–53.
    Direct Link:
  • Bialik, S. & Kimchi, A. (2004) DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death. Seminars in Cancer Biology, 14, 283–294.
  • Borsello, T., Croquelois, K., Hornung, J.P. & Clarke, P.G. (2003) N-methyl-d-aspartate-triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by the c-Jun N-terminal kinase pathway. European Journal of Neuroscience, 18, 473–485.
    Direct Link:
  • Bossy-Wetzel, E., Bakiri, L. & Yaniv, M. (1997) Induction of apoptosis by the transcription factor c-Jun. EMBO Journal, 16, 1695–1709.
  • Cande, C., Vahsen, N., Garrido, C. & Kroemer, G. (2004) Apoptosis-inducing factor (AIF): caspase-independent after all. Cell Death and Differentiation, 11, 591–595.
  • Chou, T.C. & Talalay, P. (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation, 22, 27–55.
  • Cox, J.S., Chapman, R.E. & Walter, P. (1997) The unfolded protein response coordinates the production of endoplasmic reticulum protein and endoplasmic reticulum membrane. Molecular Biology of the Cell, 8, 1805–1814.
  • Cregan, S.P., Dawson, V.L. & Slack, R.S. (2004) Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene, 23, 2785–2796.
  • Daido, S., Kanzawa, T., Yamamoto, A., Takeuchi, H., Kondo, Y. & Kondo, S. (2004) Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Research, 64, 4286–4293.
  • Damiano, J.S., Cress, A.E., Hazlehurst, L.A., Shtil, A.A. & Dalton, W.S. (1999) Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood, 93, 1658–1667.
  • Daugas, E., Susin, S.A., Zamzami, N., Ferri, K.F., Irinopoulou, T., Larochette, N., Prevost, M.C., Leber, B., Andrews, D., Penninger, J. & Kroemer, G. (2000) Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB Journal, 14, 729–739.
  • Davis, R.J. (2000) Signal transduction by the JNK group of MAP kinases. Cell, 103, 239–252.
  • De Schrijver, E., Brusselmans, K., Heyns, W., Verhoeven, G. & Swinnen, J.V. (2003) RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Research, 63, 3799–3804.
  • Gabrielson, E.W., Pinn, M.L., Testa, J.R. & Kuhajda, F.P. (2001) Increased fatty acid synthase is a therapeutic target in mesothelioma. Clinical Cancer Research, 7, 153–157.
  • Hayashi, T., Hideshima, T., Akiyama, M., Richardson, P., Schlossman, R.L., Chauhan, D., Munshi, N.C., Waxman, S. & Anderson, K.C. (2002) Arsenic trioxide inhibits growth of human multiple myeloma cells in the bone marrow microenvironment. Molecular Cancer Therapeutics, 1, 851–860.
  • Hazlehurst, L.A., Damiano, J.S., Buyuksal, I., Pledger, W.J. & Dalton, W.S. (2000) Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene, 19, 4319–4327.
  • Heiligtag, S.J., Bredehorst, R. & David, K.A. (2002) Key role of mitochondria in cerulenin-mediated apoptosis. Cell Death and Differentiation, 9, 1017–1025.
  • Hideshima, T., Chauhan, D., Shima, Y., Raje, N., Davies, F.E., Tai, Y.T., Treon, S.P., Lin, B., Schlossman, R.L., Richardson, P., Muller, G., Stirling, D.I. & Anderson, K.C. (2000) Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood, 96, 2943–2950.
  • Hideshima, T., Nakamura, N., Chauhan, D. & Anderson, K.C. (2001) Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene, 20, 5991–6000.
  • Hideshima, T., Bergsagel, P.L., Kuehl, W.M. & Anderson, K.C. (2004) Advances in biology of multiple myeloma: clinical applications. Blood, 104, 607–618.
  • Hideshima, T., Mitsiades, C., Tonon, G., Richardson, P.G. & Anderson, K.C. (2007) Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nature Reviews Cancer, 7, 585–598.
  • Inbal, B., Bialik, S., Sabanay, I., Shani, G. & Kimchi, A. (2002) DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. Journal of Cell Biology, 157, 455–468.
  • Ishitsuka, K., Hideshima, T., Hamasaki, M., Raje, N., Kumar, S., Podar, K., Le Gouill, S., Shiraishi, N., Yasui, H., Roccaro, A.M., Tai, Y.Z., Chauhan, D., Fram, R., Tamura, K., Jain, J. & Anderson, K.C. (2005) Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway. Oncogene, 24, 5888–5896.
  • Jaattela, M. & Tschopp, J. (2003) Caspase-independent cell death in T lymphocytes. Nature Immunology, 4, 416–423.
  • Jia, G., Cheng, G., Gangahar, D.M. & Agrawal, D.K. (2006) Insulin-like growth factor-1 and TNF-alpha regulate autophagy through c-jun N-terminal kinase and Akt pathways in human atherosclerotic vascular smooth cells. Immunology and Cell Biology, 84, 448–454.
    Direct Link:
  • Jochum, W., Passegue, E. & Wagner, E.F. (2001) AP-1 in mouse development and tumorigenesis. Oncogene, 20, 2401–2412.
  • Jourdan, M., De Vos, J., Mechti, N. & Klein, B. (2000) Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1. Cell Death and Differentiation, 7, 1244–1252.
  • Kaufman, R.J. (2004) Regulation of mRNA translation by protein folding in the endoplasmic reticulum. Trends in Biochemical Sciences, 29, 152–158.
  • Kelley, S.K. & Ashkenazi, A. (2004) Targeting death receptors in cancer with Apo2L/TRAIL. Current Opinion in Pharmacology, 4, 333–339.
  • Kridel, S.J., Axelrod, F., Rozenkrantz, N. & Smith, J.W. (2004) Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Research, 64, 2070–2075.
  • Kuhajda, F.P. (2000) Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition, 16, 202–208.
  • Kuhajda, F.P. (2006) Fatty acid synthase and cancer: new application of an old pathway. Cancer Research, 66, 5977–5980.
  • Kuhajda, F.P., Pizer, E.S., Li, J.N., Mani, N.S., Frehywot, G.L. & Townsend, C.A. (2000) Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proceedings of the National Academy of Sciences of the United States of America, 97, 3450–3454.
  • Kyle, R.A. & Rajkumar, S.V. (2004) Multiple myeloma. New England Journal of Medicine, 351, 1860–1873.
  • Li, J., Lee, B. & Lee, A.S. (2006) Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. Journal of Biological Chemistry, 281, 7260–7270.
  • Little, J.L., Wheeler, F.B., Fels, D.R., Koumenis, C. & Kridel, S.J. (2007) Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells. Cancer Research, 67, 1262–1269.
  • Lockshin, R.A. & Zakeri, Z. (2004) Caspase-independent cell death? Oncogene, 23, 2766–2773.
  • McCafferty-Grad, J., Bahlis, N.J., Krett, N., Aguilar, T.M., Reis, I., Lee, K.P. & Boise, L.H. (2003) Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells. Molecular Cancer Therapeutics, 2, 1155–1164.
  • Menendez, J.A. & Lupu, R. (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nature Reviews Cancer, 7, 763–777.
  • Milgraum, L.Z., Witters, L.A., Pasternack, G.R. & Kuhajda, F.P. (1997) Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clinical Cancer Research, 3, 2115–2120.
  • Mitsiades, C.S., Mitsiades, N., Poulaki, V., Schlossman, R., Akiyama, M., Chauhan, D., Hideshima, T., Treon, S.P., Munshi, N.C., Richardson, P.G. & Anderson, K.C. (2002) Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene, 21, 5673–5683.
  • Mitsiades, C.S., Mitsiades, N.S., McMullan, C.J., Poulaki, V., Shringarpure, R., Akiyama, M., Hideshima, T., Chauhan, D., Joseph, M., Libermann, T.A., Garcia-Echeverria, C., Pearson, M.A., Hofmann, F., Anderson, K.C. & Kung, A.L. (2004) Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. Cancer Cell, 5, 221–230.
  • Moche, M., Schneider, G., Edwards, P., Dehesh, K. & Lindqvist, Y. (1999) Structure of the complex between the antibiotic cerulenin and its target, beta-ketoacyl-acyl carrier protein synthase. Journal of Biological Chemistry, 274, 6031–6034.
  • Nakamura, M., Gotoh, T., Okuno, Y., Tatetsu, H., Sonoki, T., Uneda, S., Mori, M., Mitsuya, H. & Hata, H. (2006) Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells. Leukemia & Lymphoma, 47, 531–539.
  • Omura, S. (1976) The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacteriological Reviews, 40, 681–697.
  • Park, K.J., Lee, S.H., Kim, T.I., Lee, H.W., Lee, C.H., Kim, E.H., Jang, J.Y., Choi, K.S., Kwon, M.H. & Kim, Y.S. (2007) A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells. Cancer Research, 67, 7327–7334.
  • Pelled, D., Raveh, T., Riebeling, C., Fridkin, M., Berissi, H., Futerman, A.H. & Kimchi, A. (2002) Death-associated protein (DAP) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons. Journal of Biological Chemistry, 277, 1957–1961.
  • Pizer, E.S., Jackisch, C., Wood, F.D., Pasternack, G.R., Davidson, N.E. & Kuhajda, F.P. (1996a) Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Research, 56, 2745–2747.
  • Pizer, E.S., Wood, F.D., Pasternack, G.R. & Kuhajda, F.P. (1996b) Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Research, 56, 745–751.
  • Pizer, E.S., Pflug, B.R., Bova, G.S., Han, W.F., Udan, M.S. & Nelson, J.B. (2001) Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression. Prostate, 47, 102–110.
    Direct Link:
  • Podar, K., Raab, M.S., Tonon, G., Sattler, M., Barila, D., Zhang, J., Tai, Y.T., Yasui, H., Raje, N., DePinho, R.A., Hideshima, T., Chauhan, D. & Anderson, K.C. (2007) Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma. Cancer Research, 67, 1680–1688.
  • Raje, N., Kumar, S., Hideshima, T., Ishitsuka, K., Chauhan, D., Mitsiades, C., Podar, K., Le Gouill, S., Richardson, P., Munshi, N.C., Stirling, D.I., Antin, J.H. & Anderson, K.C. (2004) Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma. Blood, 104, 4188–4193.
  • Richardson, P., Hideshima, T. & Anderson, K.C. (2004) An update of novel therapeutic approaches for multiple myeloma. Current Treatment Options in Oncology, 5, 227–238.
  • Rossi, S., Graner, E., Febbo, P., Weinstein, L., Bhattacharya, N., Onody, T., Bubley, G., Balk, S. & Loda, M. (2003) Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Molecular Cancer Research, 1, 707–715.
  • Van Der Sanden, M.H., Meems, H., Houweling, M., Helms, J.B. & Vaandrager, A.B. (2004) Induction of CCAAT/enhancer-binding protein (C/EBP)-homologous protein/growth arrest and DNA damage-inducible protein 153 expression during inhibition of phosphatidylcholine synthesis is mediated via activation of a C/EBP-activating transcription factor-responsive element. Journal of Biological Chemistry, 279, 52007–52015.
  • Sriburi, R., Jackowski, S., Mori, K. & Brewer, J.W. (2004) XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. Journal of Cell Biology, 167, 35–41.
  • Swinnen, J.V., Van Veldhoven, P.P., Timmermans, L., De Schrijver, E., Brusselmans, K., Vanderhoydonc, F., Van de Sande, T., Heemers, H., Heyns, W. & Verhoeven, G. (2003) Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains. Biochemical and Biophysical Research Communications, 302, 898–903.
  • Szegezdi, E., Logue, S.E., Gorman, A.M. & Samali, A. (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Reports, 7, 880–885.
  • Tessitore, A., Del, P.M.M., Sano, R., Ma, Y., Mann, L., Ingrassia, A., Laywell, E.D., Steindler, D.A., Hendershot, L.M. & D’Azzo, A. (2004) GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Molecular Cell, 15, 753–766.
  • Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H.P. & Ron, D. (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science, 287, 664–666.
  • Vance, D., Goldberg, I., Mitsuhashi, O. & Bloch, K. (1972) Inhibition of fatty acid synthetases by the antibiotic cerulenin. Biochemical and Biophysical Research Communications, 48, 649–656.
  • Vande Velde, C., Cizeau, J., Dubik, D., Alimonti, J., Brown, T., Israels, S., Hakem, R. & Greenberg, A.H. (2000) BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Molecular and Cellular Biology, 20, 5454–5468.
  • Vogt, P.K. (2001) Jun, the oncoprotein. Oncogene, 20, 2365–2377.
  • Wakil, S.J. (1989) Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry, 28, 4523–4530.
  • Weston, C.R. & Davis, R.J. (2007) The JNK signal transduction pathway. Current Opinion in Cell Biology, 19, 142–149.
  • Xu, C., Bailly-Maitre, B. & Reed, J.C. (2005) Endoplasmic reticulum stress: cell life and death decisions. Journal of Clinical Investigation, 115, 2656–2664.
  • Yamamoto, M., Hioki, T., Ishii, T., Nakajima-Iijima, S. & Uchino, S. (2002) DAP kinase activity is critical for C(2)-ceramide-induced apoptosis in PC12 cells. European Journal of Biochemistry, 269, 139–147.
    Direct Link:
  • Yu, L., Alva, A., Su, H., Dutt, P., Freundt, E., Welsh, S., Baehrecke, E.H. & Lenardo, M.J. (2004) Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science, 304, 1500–1502.
  • Zhao, L. & Ackerman, S.L. (2006) Endoplasmic reticulum stress in health and disease. Current Opinion in Cell Biology, 18, 444–452.
View Full Article with Supporting Information (HTML) Get PDF (876K)